Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Thai Orchid opens Northland location with homey street food set to wow its new neighbors
Even though the new Thai Orchid restaurant in Kansas City’s Northland proudly pays homage to the Rojjanasrirat family’s culinary legacy in Mission, its second-generation owner wants to shock the taste buds of diners who are unfamiliar with the business’ story. “I want the reaction of the people who try our food to be, ‘Wow! That’s…
C2FO accesses $30M investment with World Bank-backed IFC to expand KC firm’s working capital platform
A just-announced capital infusion for Leawood-built C2FO reflects a shared commitment with global partners to boosting jobs and strengthening economic opportunities — notably for micro, small and medium enterprises in emerging markets worldwide. The $30 million funding round features investment from the International Finance Corporation (IFC), a member of the World Bank Group, and existing…
Park capping I-670 gets an official name: South Loop project to honor longtime Republican bridge-builder
Kansas City’s high-profile South Loop Project — a proposed sustainable urban park capping a portion of I-670 — now has a name that pays homage to a leader who played a key role in launching the project: Roy Blunt Luminary Park. “As a working title, the South Loop Project has served us well,” said Jeff…
Not just a pet project: Why this KC e-commerce team adopted a dog supplement brand as its own
The Morgans — the family behind Marknology, a bootstrapped digital marketing firm specializing in Amazon sales — are taking a dog supplement brand that they built as a client to the next level now as owners, they shared. Waggedy — veterinarian-formulated supplements to keep dogs healthy and active, launched by Ben Bellinson in 2015 in…